<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang X</submitter><funding>Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>4529</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12081701</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Latent HIV-1 presents a formidable challenge for viral eradication. HIV-1 transcription and latency reversal require interactions between the viral promoter and host proteins. Here, we perform the dCas9-targeted locus-specific protein analysis and discover the interaction of human arginine methyltransferase 3 (PRMT3) with the HIV-1 promoter. This interaction reverses latency in cell line models and primary cells from latently infected persons by increasing the levels of H4R3Me2a and transcription factor P-TEFb at the viral promoter. PRMT3 is found to promote chromatin accessibility and transcription of HIV-1 and a small subset of host genes in regions harboring the classical recognition motif for another transcription factor TEAD4. This motif attracts TEAD4 and PRMT3 to the viral promoter </pubmed_abstract><journal>Nature communications</journal><pubmed_title>PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub.</pubmed_title><pmcid>PMC12081701</pmcid><funding_grant_id>31900132</funding_grant_id><funding_grant_id>32470588</funding_grant_id><funding_grant_id>7232052</funding_grant_id><pubmed_authors>Yao K</pubmed_authors><pubmed_authors>Chong H</pubmed_authors><pubmed_authors>Zhou Q</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Wan L</pubmed_authors><pubmed_authors>Fan M</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Yu D</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Jia L</pubmed_authors><pubmed_authors>Song J</pubmed_authors><pubmed_authors>Xue Y</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Lu L</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Lin D</pubmed_authors><pubmed_authors>Xiang Z</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Su W</pubmed_authors></additional><is_claimable>false</is_claimable><name>PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub.</name><description>Latent HIV-1 presents a formidable challenge for viral eradication. HIV-1 transcription and latency reversal require interactions between the viral promoter and host proteins. Here, we perform the dCas9-targeted locus-specific protein analysis and discover the interaction of human arginine methyltransferase 3 (PRMT3) with the HIV-1 promoter. This interaction reverses latency in cell line models and primary cells from latently infected persons by increasing the levels of H4R3Me2a and transcription factor P-TEFb at the viral promoter. PRMT3 is found to promote chromatin accessibility and transcription of HIV-1 and a small subset of host genes in regions harboring the classical recognition motif for another transcription factor TEAD4. This motif attracts TEAD4 and PRMT3 to the viral promoter </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-01T23:01:41.492Z</modification><creation>2026-05-23T03:08:16.754Z</creation></dates><accession>S-EPMC12081701</accession><cross_references><pubmed>40374607</pubmed><doi>10.1038/s41467-025-59578-5</doi></cross_references></HashMap>